A comparison of two ELISAs for detecting HBe markers

Area of Science:

• Hepatology
• Immunology
• Diagnostic Assay Development

Background:

• Hepatitis B virus (HBV) infection is a major global health concern.
• Hepatitis Be antigen (HBeAg) and antibody (anti-HBe) are crucial markers for inferring HBV infectivity.
• Accurate and efficient detection of these markers is essential for patient management.

Purpose of the Study:

• To evaluate a new enzyme-linked immunosorbent assay (ELISA) kit for HBeAg and anti-HBe detection.
• To compare the performance of the new kit against an established ELISA method.
• To assess the speed, sensitivity, specificity, and ease of use of the novel diagnostic tool.

Main Methods:

• Comparison of a new ELISA kit (Wellcozyme HBeAg/anti-HBe) with a standard laboratory ELISA.
• Testing of 109 patient samples for HBeAg and anti-HBe.
• Evaluation of assay completion time, sensitivity, specificity, and procedural simplicity.

Main Results:

• The new ELISA kit provides results within 2 hours, significantly faster than the current 19-hour test.
• There was a high degree of agreement (97%, 106/109 samples) between the new kit and the established method.
• The new test demonstrated acceptable sensitivity and specificity, with straightforward performance.

Conclusions:

• The new Wellcozyme HBeAg/anti-HBe ELISA kit is a rapid, reliable, and user-friendly alternative for detecting HBV infectivity markers.
• This faster assay has the potential to improve diagnostic workflow in clinical laboratories.
• The high concordance supports its clinical utility in managing patients with hepatitis B surface antigenaemia.